Ronald B. Herberman
#50,844
Most Influential Person Now
American immunologist and oncologist
Ronald B. Herberman's AcademicInfluence.com Rankings
Ronald B. Herbermanmedical Degrees
Medical
#307
World Rank
#447
Historical Rank
#135
USA Rank
Oncology
#5
World Rank
#6
Historical Rank
#3
USA Rank
Ronald B. Herbermanbiology Degrees
Biology
#1721
World Rank
#2801
Historical Rank
#826
USA Rank
Immunology
#47
World Rank
#51
Historical Rank
#18
USA Rank
Download Badge
Medical Biology
Ronald B. Herberman's Degrees
- Masters Medicine University of Pittsburgh
Why Is Ronald B. Herberman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ronald Bruce Herberman was an American physician, immunologist, oncologist, and professor of medicine and pathology who founded the University of Pittsburgh Cancer Institute , a National Cancer Institute-designated Comprehensive Care Center in 1984. He helped discover natural killer cells capable of killing cancer. He became well known outside the medical community in 2008 for his public warning about the potential health impacts of mobile telephones and recommending a reduction in their use.
Ronald B. Herberman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Natural killer cells: their roles in defenses against disease. (1981) (1347)
- Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity (1975) (1334)
- Natural cell-mediated immunity. (1978) (1019)
- Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells (1975) (869)
- Augmentation of mouse natural killer cell activity by interferon and interferon inducers. (1979) (604)
- Natural Killer Cells: Characteristics and Regulation of Activity (1979) (578)
- Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. (1998) (518)
- Lymphocyte-mediated cytotoxicity. (1987) (517)
- Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. (1977) (458)
- Inhibition of murine natural killer cell activity by prostaglandins. (1980) (411)
- Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells (1989) (393)
- Role of NK cells in the control of metastatic spread and growth of tumor cells in mice (1982) (375)
- Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. (1981) (368)
- Natural cell-mediated immunity against tumors (1980) (346)
- Heterogeneity of natural killer cells. (1984) (346)
- EVIDENCE OF SUPPRESSOR CELL ACTIVITY IN SPLEENS OF MICE BEARING PRIMARY TUMORS INDUCED BY MOLONEY SARCOMA VIRUS (1974) (325)
- A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. (1977) (309)
- Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. (1985) (307)
- The role of natural killer cells in immune surveillance of cancer. (1995) (305)
- Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. (1985) (294)
- Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. (1987) (293)
- IL-18–induced CD83+CCR7+ NK helper cells (2005) (288)
- Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells (1977) (285)
- The Reticuloendothelial System (2012) (280)
- Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. (1989) (280)
- Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. (1984) (279)
- Mechanism of cytotoxicity by natural killer (NK) cells. (1986) (275)
- Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. (1981) (275)
- Cell-mediated immunity to tumor cells. (1974) (274)
- Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. (1985) (256)
- Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. (1987) (250)
- Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer (2005) (249)
- Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. (1990) (243)
- Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bank (1984) (235)
- Calculation of lytic units for the expression of cell-mediated cytotoxicity. (1992) (233)
- Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. (1999) (230)
- The role of natural killer cells in human disease. (1989) (229)
- Natural killer cells. (1986) (227)
- Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. (1987) (223)
- Interleukin 2 dependence of human natural killer (NK) cell activity. (1983) (218)
- Human large granular lymphocytes are potent producers of interleukin-1 (1984) (213)
- Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. (1990) (198)
- Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice. (1975) (193)
- Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses (1982) (188)
- In vivo natural reactivity of mice against tumor cells (1980) (183)
- Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. (1974) (183)
- Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. (1978) (181)
- Chediak-Higashi gene in humans. I. Impairment of natural - killer function (1980) (180)
- Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver (1984) (175)
- Role of human natural killer cells in health and disease (1994) (173)
- Rapid in vivo assay of mouse natural killer cell activity. (1979) (173)
- Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. (1983) (172)
- Cytolytic and cytostatic activity on tumor cells of circulating human monocytes (1979) (172)
- Natural killer cytotoxicity in the diagnosis of immune dysfunction: Criteria for a reproducible assay (1990) (171)
- Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon. (1979) (167)
- In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. (1983) (163)
- Isolation of human and rat natural killer cells. (1982) (162)
- Cytotoxic reactivity of human lymphocytes cultured in vitro. (1977) (161)
- Natural Killer Cells as Antitumor Effector (1979) (161)
- Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. (1991) (159)
- Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. (2007) (159)
- Modulation of human natural killer cell activity by exposure to uncontrollable stress (1992) (157)
- Defining the critical hurdles in cancer immunotherapy (2011) (152)
- Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. (1982) (151)
- Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. (1977) (149)
- Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells (1988) (146)
- Natural killer cells and tumor therapy. (1998) (145)
- Natural cell‐mediated cytotoxicity in rats. II. In vivo augmentation of NK‐cell activity (1978) (144)
- Exposure Limits: The underestimation of absorbed cell phone radiation, especially in children (2012) (144)
- Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. (2010) (141)
- Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity. (1982) (141)
- Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. (1987) (141)
- Natural killer cell reactivity: regulatory interactions and among phorbol ester, interferon, cholera toxin, and retinoic acid. (1981) (140)
- Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. (1978) (140)
- Natural killer cells. (1989) (139)
- Lymphocyte cytotoxicity reactions to leukemia‐associated antigens in identical twins (1972) (139)
- Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition (1976) (138)
- Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. (1975) (138)
- Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma. (1974) (137)
- Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases (1991) (137)
- Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. (1981) (137)
- Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission. (1988) (134)
- Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. (1986) (132)
- Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. (1987) (131)
- Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene. (1998) (130)
- Isolation, phenotyping, and functional analysis of lymphocytes from human liver. (1990) (127)
- Specificity of cellular immune reactivity to virus-induced tumours. (1972) (123)
- Specificity of 5lCr-Release Cytotoxicity of Lymphocytes Immune to Murine Sarcoma Virus (1974) (122)
- Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays. (1975) (122)
- Inhibition of rat mixed lymphocyte cultures by suppressor macrophages. (1977) (121)
- A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. (1988) (119)
- Natural cell‐mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic‐polycytidylic acid (1978) (118)
- Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. (1976) (116)
- Mediation of mouse natural cytotoxic activity by tumour necrosis factor (1986) (116)
- Generation and characterization of purified adherent lymphokine-activated killer cells in mice. (1989) (115)
- Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes (1983) (114)
- Breast conservation versus mastectomy: distress sequelae as a function of choice. (1989) (112)
- A species of human alpha interferon that lacks the ability to boost human natural killer activity. (1984) (110)
- Natural killer–dendritic cell cross-talk in cancer immunotherapy (2005) (110)
- Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. (1998) (109)
- Augmentation of human monocyte-mediated cytolysis by interferon. (1980) (108)
- Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells. (1971) (108)
- Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. (1993) (108)
- Rosette Formation by the Human K Cell (1978) (107)
- Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. (1981) (107)
- Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma. (1976) (107)
- Chediak-Higashi gene in humans. II. The selectivity of the defect in natural- killer and antibody-dependent cell-mediated cytotoxicity function (1980) (107)
- Depletion of monocytes from human peripheral blood mononuclear leukocytes: comparison of the sephadex G-10 column method with other commonly used techniques. (1980) (105)
- Fc receptors on mouse effector cells mediating natural cytotoxicity against tumor cells. (1977) (103)
- Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. (1986) (103)
- Natural cytotoxicity of mouse monocytes and macrophages. (1979) (103)
- Expression and function of CD7 molecule on human natural killer cells. (1994) (103)
- Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells. (1974) (102)
- Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. (1993) (102)
- Identification and separation of Thy-1 positive mouse spleen cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. (1979) (101)
- Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. (1970) (100)
- Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. (1985) (99)
- Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors. (1981) (99)
- In vitro augmentation of rat natural killer (NK) cell activity. (1981) (98)
- Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. (1983) (98)
- Reactivity of Anti‐Asialo GM1 Serum With Tumoricidal and Non‐Tumoricidal Mouse Macrophages (1985) (95)
- Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors. (1988) (95)
- Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial (2014) (95)
- Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells. (1970) (94)
- Nonsecretory apoptotic killing by human NK cells. (1996) (94)
- Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity. (1980) (93)
- Biological significance of prolactin in gynecologic cancers. (2009) (93)
- Immune reactivity of leukemia patients to autologous blast cells. (1972) (91)
- Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors. (1987) (90)
- Potent activation of mouse macrophages by recombinant interferon-gamma. (1984) (88)
- Expression of fetal antigens in tumor cells. (1972) (88)
- The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I:C. (1979) (87)
- Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. (1992) (87)
- T-cell homeostasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host (1997) (86)
- Mastectomy versus breast conservation surgery: mental health effects at long-term follow-up. (1992) (86)
- Cultures of purified human natural killer cells: growth in the presence of interleukin 2. (1982) (86)
- Separation of Skin Reactive Intestinal Cancer Antigen from the Carcinoembryonic Antigen of Gold (1972) (85)
- Natural killer activity in the rat. IV. Distribution of large granular lymphocytes (LGL) following intravenous and intraperitoneal transfer. (1984) (84)
- Immunobiology of Natural Killer Cells (1986) (84)
- Expression of mRNA for cytokines in tumor‐infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer (1992) (82)
- The effect of lentinan on production of interleukin-1 by human monocytes. (1982) (82)
- Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity. (1991) (82)
- ROLE OF INTERFERON IN REGULATION OF CYTOTOXICITY BY NATURAL KILLER CELLS AND MACROPHAGES (1980) (82)
- Mechanisms of Cytotoxicity by Nk Cells (1985) (82)
- Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells. (1993) (82)
- The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers. (1986) (81)
- Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor. (1977) (80)
- Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations. (1979) (80)
- Enzyme-linked immunosorbent assay for screening monoclonal antibody production: use of intact cells as antigen. (1980) (79)
- Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens. (1970) (79)
- Natural killer cell activity in the rat. Analysis of effector cell morphology and effects of interferon on natural killer cell function in the athymic (nude) rat (1982) (78)
- Methionine enkephalin: a new cytokine--human studies. (1997) (78)
- Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: twenty-four-hour versus 7-day infusion. (1997) (77)
- Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo (1980) (76)
- Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. (1993) (76)
- Augmentation of metastasis formation by thioglycollate‐elicited macrophages (1982) (75)
- Effects of adriamycin on the activity of mouse natural killer cells. (1980) (75)
- Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. (1976) (74)
- Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues. (1995) (74)
- Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission. (1988) (74)
- Dysfunction of natural killer activity in a family with chronic fatigue syndrome. (1998) (74)
- In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice. (1973) (74)
- Ig-binding Receptors on Human NK Cells as Effector and Regulatory Surface Molecules (2001) (74)
- Inhibition of in vitro lymphoproliferative responses to tumor‐associated antigens by suppressor cells from rats bearing progressively growing gross leukemia virus‐induced tumors (1975) (73)
- Serological analysis of cell surface antigens of tumors induced by murine leukemia virus. (1972) (73)
- Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. (1991) (73)
- Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL). (1986) (72)
- Effects of recombinant and hybrid recombinant human leukocyte interferons on cytotoxic activity of natural killer cells. (1983) (72)
- Changes of liver-resident NK cells during liver regeneration in rats. (1995) (71)
- Adoptive Immunotherapy of Cancer (1994) (71)
- Allelic polymorphisms in the FcγRIIC gene can influence its function on normal human natural killer cells (2002) (70)
- IMMUNE AND NATURAL ANTIBODIES TO SYNGENEIC MURINE PLASMA CELL TUMORS (1972) (70)
- The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures (1990) (69)
- Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. (1992) (69)
- Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. (1975) (68)
- Functional activities of rosette separated human peripheral blood leukocytes. (1975) (68)
- Cellular microcytotoxicity in human tumor systems: analysis of results. (1975) (68)
- Natural killer activity of human liver‐derived lymphocytes in various liver diseases (1991) (66)
- Immunological monitoring and immunotherapy in carcinoma of the lung (1976) (65)
- Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. (1991) (65)
- Augmentation of tumoricidal activity of human monocytes and macrophages by lymphokines (1980) (65)
- Immunologic approaches to the diagnosis of cancer (1976) (65)
- Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors. (1974) (64)
- Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. (1991) (64)
- Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes. (1987) (64)
- Cancer immunotherapy with natural killer cells. (2002) (64)
- Inhibition of human natural killer cell reactivity by exogenous adenosine 5'-triphosphate. (1984) (64)
- Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes. (1989) (63)
- H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity. (1988) (63)
- Tumor‐localization by adoptively transferred, interleukin‐2‐activated NK cells leads to destruction of well‐established lung metastases (2003) (62)
- Immunoregulation and natural killer cells. (1982) (62)
- Cytolytic activity of circulating human monocytes on transformed and untransformed human fibroblasts (1979) (61)
- Cryopreservation of human lymphocyte function as measured by in vitro assays (1976) (61)
- Soluble membrane antigens of human malignant melanoma cells (1974) (61)
- Tumor markers in cancer diagnosis and prognosis (1988) (61)
- An isotopic antiglobulin technique for measuring antibodies to cell-surface antigens. (1969) (60)
- Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells. (1973) (60)
- Cytotoxic effector cells with the characteristics of natural killer cells in the lungs of mice (1980) (60)
- Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity. (1980) (60)
- Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. (2002) (59)
- A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses. (1982) (59)
- Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. (1991) (58)
- Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells. (1993) (58)
- Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells. (1994) (58)
- Immune response to Gross virus-induced lymphoma. II. Kinetics of the cellular immune response. (1971) (58)
- Suppression of activity of mouse natural killer (NK) cells by activated macrophages from mice treated with pyran copolymer (1980) (58)
- Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine. (1985) (57)
- Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease (1992) (57)
- Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response. (1972) (57)
- In vivo reactivity of mouse natural killer (NK) cells against normal bone marrow cells. (1981) (56)
- Inhibition of human natural killer cell activity by cytophilic immunoglobulin G. (1982) (56)
- Intralesional treatment of recurrent metastatic cutaneous malignant melanoma. A randomized prospective study of intralesional bacillus calmette‐guerin versus intralesional dinitrochlorobenzene (1978) (56)
- Selective depletion of human natural killer cells on monolayers of target cells. (1980) (55)
- Interleukin-2 therapy of human cancer: potential benefits versus toxicity. (1989) (55)
- Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines (1985) (55)
- Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects. (1993) (55)
- Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein. (1983) (55)
- Low NK syndrome and its relationship to chronic fatigue syndrome. (1993) (55)
- Modulation of immunity by macrophages (1985) (54)
- Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates. (1989) (54)
- Role of natural killer activity in development of spontaneous metastases in murine renal cancer. (1985) (54)
- Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice. (1975) (53)
- Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors. (1987) (53)
- Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity. (1979) (52)
- The T-Cell Receptor Vβ Gene Usage in Tumor-infiltrating Lymphocytes and Blood of Patients with Hepatocellular Carcinoma (1992) (52)
- Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion. (1993) (52)
- The circulating lymphocyte--its role in infectious mononucleosis. (1968) (52)
- Cytostasis of tumor cell lines by human granulocytes. (1980) (52)
- Inhibition of the activity of mouse natural killer cells by urethan. (1981) (51)
- T Cell Turnover in SIV Infection (1999) (51)
- Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. (1989) (51)
- Modulation of IL 2-dependent growth of mouse NK cells by interferon and T lymphocytes. (1983) (50)
- Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE. (1985) (50)
- Regulation of Natural Killer Cell Activity (1984) (50)
- Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines. (1981) (50)
- Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. I. Distribution of the reactivity. (1979) (50)
- Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay. (1977) (50)
- The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer. (1990) (50)
- Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells. (1974) (49)
- In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells. (1988) (49)
- Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells. (1979) (49)
- Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma. (1974) (49)
- Wild-Type Gross Leukemia Virus: Classification of Soluble Antigens (GSA) (1972) (49)
- Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic (2011) (48)
- Possible role of natural killer cells and other effector cells in immune surveillance against cancer. (1984) (48)
- Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. (1988) (48)
- Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2. (1990) (48)
- Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. (1991) (48)
- In vitro inhibition of lymphoproliferative responses to tumor associated antigens and of lymphoma cell proliferation by rat splenic macrophages. (1977) (48)
- Relationship of human natural lymphocyte‐mediated cytotoxicity to cytotoxicity of breast‐cancer‐derived target cells (1977) (48)
- A phase I trial of recombinant gamma interferon in patients with cancer (2004) (47)
- Radioisotope assay for evaluation of in vivo natural cell‐mediated resistance of mice to local transplantation of tumor cells (1981) (47)
- Tumor-infiltrating lymphocytes (1992) (47)
- Increased monocyte‐mediated cytostasis of lymphoid cell lines in breast and lung cancer patients (1979) (46)
- IN VITRO ACTIVATION OF CELLULAR IMMUNE RESPONSE TO GROSS VIRUS-INDUCED LYMPHOMA (1972) (46)
- Inhibition of the mixed lymphocyte culture by peritoneal exudate cells. (1976) (46)
- Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells. (2002) (46)
- Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response. (1971) (46)
- Augmentation of Human K‐Cell Activity with Interferon (1980) (46)
- Induction of tumor regression in experimental model of human head and neck cancer by human a‐lak cells and IL‐2 (1991) (45)
- Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors. (1983) (45)
- Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells. (1975) (45)
- Cutaneous delayed hypersensitivity responses to tumor‐associated and other antigens in acute leukemia (1973) (45)
- Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. (1988) (45)
- Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity. (1981) (44)
- Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity. (1985) (44)
- Suppression of natural killer (NK) activity by splenic adherent cells of low NK‐reactive mice (1981) (43)
- SUPPRESSION OF MIXED LYMPHOCYTE RESPONSE IN MICE BEARING PRIMARY TUMORS INDUCED BY MURINE SARCOMA VIRUS (1976) (43)
- Immunologic reactivity of lymphoid cells in tumors. (1980) (43)
- Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells. (1979) (43)
- Cytotoxic activities of normal cultured human T cells. (1978) (43)
- The suppression of mitogen- and alloantigen-stimulated peripheral blood lymphocytes by cultured human T lymphocytes. (1979) (43)
- Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. (1978) (43)
- Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes. (1986) (42)
- Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells. (1973) (42)
- Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells. (1984) (42)
- Characteristics of natural killer cells and lymphokine-activated killer cells : their role in the biology and treatment of human cancer (1990) (42)
- Macrophages as regulators of immune responses against tumors. (1979) (42)
- Low natural killer syndrome: clinical and immunologic features. (1987) (41)
- Gene Amplification and Gene Dosage in Cell Lines Derived From Squamous Cell Carcinoma of the Head and Neck (1991) (41)
- THE EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON CELLULAR AND SUBCELLULAR MEMBRANES (1965) (41)
- Persistently low natural killer cell activity and circulating levels of plasma beta endorphin: risk factors for infectious disease. (1991) (41)
- 51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells. (1973) (41)
- Depression of Murine Macrophage Accumulation by Low-Molecular-Weight Factors Derived From Spontaneous Mammary Carcinomas (1980) (40)
- Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. (1986) (40)
- A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation (CCE). (1983) (40)
- Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model. (1990) (40)
- An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity. (1973) (40)
- Beta1 integrin-mediated activation of focal adhesion kinase and its association with Fyn and Zap-70 in human NK cells. (1996) (40)
- Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. (1994) (39)
- Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages. (1977) (39)
- Evaluation of the role of IgG antibodies in human natural cell-mediated cytotoxicity against the myeloid cell line K562. (1979) (39)
- From HIV infection to AIDS: are the manifestations of effective immune resistance misinterpreted? (1993) (39)
- Production of plasminogen activator by human natural killer cells. Large granular lymphocytes (1984) (39)
- In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity. (1976) (38)
- Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK). (2014) (38)
- Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation. (1995) (38)
- Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer. (1996) (38)
- HLA restriction and T‐cell‐receptor Vβ gene expression of cytotoxic T lymphocytes reactive with human squamous‐cell carcinoma of the head and neck (1994) (38)
- Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity. (1973) (37)
- Natural killer cells as antitumor effector cells. (1979) (37)
- Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. II. Evidenceth Kilham rat virus is responsible for the inhibitory effect. (1977) (37)
- Reassessment of LAK phenomenology: a review. (1987) (37)
- Immunogenicity of tumor antigens. (1977) (37)
- Inverse relationship of polyoma tumour specific cell surface antigen to H-2 histocompatibility antigens. (1971) (37)
- Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy. (1992) (36)
- Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group. (1999) (36)
- Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions. (1985) (36)
- Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects. (1993) (36)
- Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells. (1982) (36)
- Low affinity E-rosette formation by the human K cell. (1978) (36)
- Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens. (1977) (35)
- Natural killer cells and their relationship to T-cells: hypothesis on the role of T-cell receptor gene rearrangement on the course of adaptive differentiation. (1986) (35)
- Functional heterogeneity between NKR-P1bright/Lycopersicon esculentum lectin (L.E.)bright and NKR-P1bright/L.E.dim subpopulations of rat natural killer cells. (1992) (35)
- Immunodiagnosis of cancer. (1990) (35)
- Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells. (1977) (35)
- Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon. (1998) (35)
- Analysis of T cell receptors in highly purified rat and human large granular lymphocytes (LGL): lack of functional 1.3 kb beta-chain mRNA. (1986) (35)
- Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma. (1975) (35)
- Abnormalities in the p53 gene in tumors and cell lines of human squamous‐cell carcinomas of the head and neck (1993) (34)
- Immunologic Aspects of Chronic Fatigue Syndrome (2004) (34)
- Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. Clinical description (1977) (34)
- Effect of alpha-interferons on immune function. (1997) (34)
- Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice. (1976) (34)
- Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer (1981) (34)
- Therapeutic Activity of NK Cells against Tumors (2001) (33)
- Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin. (1994) (33)
- Divergent effects of FcγRIIIA ligands on the functional activities of human natural killer cells in vitro (1996) (33)
- Role of natural killer (NK) cells in the control of tumor growth and metastatic spread (1986) (32)
- Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells. (1978) (32)
- Cell-mediated immunity to retinal antigens in patients with pigmentary retinal degenerations. (1974) (32)
- Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction. (1974) (32)
- Cytotoxicity against tumour-associated antigens not H–2 restricted (1977) (31)
- Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay. (1978) (31)
- Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. (1988) (31)
- Lymphocyte blastogenesis induced by potassium chloride extracts of allogeneic breast carcinoma and lymphoid cells. (1975) (31)
- Detection of tumor‐specific cell surface antigen of simian virus 40‐induced tumors by the isotopic antiglobulin technique (1971) (31)
- Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation. (1985) (31)
- Effect of monoclonal antibodies (MoAb) to class I and class II HLA antigens on lectin- and MoAb OKT3-induced lymphocyte proliferation. (1985) (31)
- In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment. (1993) (31)
- Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge. (1975) (30)
- Immunologic abnormalities in melanoma-prone families. (1979) (30)
- Adhesion characteristics of human interleukin 2-activated natural killer cells. (1991) (30)
- Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon. (1981) (30)
- Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities. (1981) (30)
- Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens. (1976) (30)
- Cell-mediated immunity to a retinoblastoma tissue culture line in patients with retinoblastoma. (1974) (30)
- Regulation of Human Large Granular Lymphocyte and T Cell Growth and Function by Recombinant Interleukin 2: Induction of Interleukin 2 Receptor and Promotion of Growth of Cells With Enhanced Cytotoxicity (1987) (30)
- Microencapsulated tumor assay: new short-term assay for in vivo evaluation of the effects of anticancer drugs on human tumor cell lines. (1987) (29)
- In vitro human reactivity to staphylococcal phage lysate. (1975) (29)
- Ligand binding specificities and signal transduction pathways of Fcγ receptor IIc isoforms: the CD32 isoforms expressed by human NK cells (1999) (29)
- Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma. (1976) (29)
- Tumor Markers and Immunodiagnosis (2003) (29)
- Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates. (1996) (29)
- Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production. (1978) (28)
- Cell‐mediated immune responsiveness of patients with acute lymphocytic leukemia in remission (1976) (28)
- In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats. (1976) (28)
- Detection of decreased proportion of lymphocytes forming rosettes with sheep erythrocytes at 29 degrees C in the blood of cancer patients. Analysis of factors affecting the assay. (1977) (28)
- Inhibition of natural cytotoxic rabbit antibody by human IgM: production of nontoxic rabbit serum for use as complement source. (1970) (28)
- Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study. (1971) (28)
- A human lymphoid cell line with receptors for both sheep red blood cells and complement. (1974) (28)
- Adriamycin-induced antitumor response in lethally irradiated mice. (1979) (28)
- Depression of natural antitumor resistance of C57BL/6 mice by leukemogenic doses of radiation and restoration of resistance by transfer of bone marrow or spleen cells from normal, but not beige, syngeneic mice. (1982) (27)
- Basic and Clinical Tumor Immunology (2013) (27)
- Natural killer cells. (1982) (27)
- Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay. (2001) (27)
- Regulation of human natural cytotoxicity by IgG--I. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity. (1987) (27)
- Cell-mediated immunity to Friend virus-induced leukemia. (1974) (27)
- Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes. (1987) (27)
- Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response. (1976) (26)
- Serological analysis of immune response to friend virus-induced leukemia. (1974) (26)
- Rationale for recombinant human interferon-gamma adjuvant immunotherapy for cancer. (1988) (26)
- Interferon activates macrophages to produce plasminogen activator. (1982) (26)
- A phase I evaluation of poly(I,C)-LC in cancer patients. (1985) (26)
- In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors. (1988) (26)
- Suppressor cells in tumor bearing mice and rats. (1976) (26)
- Depressed Ability of Patients with Melanoma or Renal Cell Carcinoma to Generate Adherent Lymphokine-Activated Killer Cells (1991) (26)
- Possible Role of Natural Killer Cells in Host Resistance Against Tumours and Other Diseases (1983) (26)
- Effect of influenza A virus infection on natural and adaptive cellular immunity. (1996) (25)
- Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients (1978) (25)
- Spontaneous CD4+ T Cell Responses against TRAG-3 in Patients with Melanoma and Breast Cancers1 (2006) (25)
- Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow. (1994) (25)
- Immunologic tests in diagnosis of cancer. (1977) (25)
- Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer. (1977) (24)
- Induction of protein tyrosine phosphorylation in human natural killer cells by triggering via alpha 4 beta 1 or alpha 5 beta 1 integrins. (1995) (24)
- Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma (1997) (24)
- The effect of specific anti-rat thymocyte serum on cell-mediated tumor immunity and other lymphocyte functions. (1974) (24)
- Direct comparison of three isotopic release microtoxicity assays as measures of cell-mediated immunity to Gross virus-induced lymphomas in rats. (1977) (24)
- Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells. (1990) (24)
- Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity. (1982) (24)
- Expression of various tumor-specific antigens in polyoma virus-induced tumors. (1972) (24)
- Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma. (1984) (24)
- Natural killer (NK) cells and their possible roles in resistance against disease. (1981) (23)
- ASSOCIATION OF HUMAN NATURAL KILLER CELL ACTIVITY AGAINST HUMAN PRIMARY TUMORS WITH LARGE GRANULAR LYMPHOCYTES (1982) (23)
- 'Immune surveillance' without immunogenicity. (1986) (23)
- Modulation of fetal antigen(s) in mouse leukemia cells. (1974) (23)
- Inhibition of activity of human NK and K cells by simple sugars: discrimination between binding and postbinding events. (1984) (23)
- Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2 (2004) (23)
- The biology of human natural killer cells. (1990) (23)
- Rapidly progressing breast cancer (poussée Évolutive) in Tunisia: Studies on delayed hypersensitivity (1978) (22)
- Nk Cell Mediated Cytotoxicity: Receptors, Signaling, and Mechanisms (1992) (22)
- Immunological Diagnosis of Leukaemia and Lymphoma: A World Health Organization/International Union of Immunological Societies Technical Report (1978) (22)
- Evaluation of role of natural killer cells in radiation-induced leukemogenesis in mice. (1984) (22)
- Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity. (1988) (22)
- Augmentation of human natural killer cell activity by interferon: conditions required for boosting and characteristics of the effector cells. (1981) (22)
- Effects of recombinant interferon-alpha on immune function in cancer patients. (1983) (22)
- Cytotoxicity from cultured cells: analysis of precursors involved in generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicity. (1979) (22)
- Sensitive and convenient quantitation of antibody binding to cellular antigens using glutaraldehyde preserved cells. (1979) (22)
- A Novel Cross-Disciplinary Multi-Institute Approach to Translational Cancer Research: Lessons Learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC) (2007) (22)
- Immunomodulation and antitumor effects of MVE-2 in mice. (1984) (22)
- Surface antigens on transplantable tumor cell lines producing mouse type C viruses. (1977) (22)
- PRODUCTION OF INTERFERON BY HUMAN NATURAL KILLER CELLS IN RESPONSE TO MITOGENS, VIRUSES AND BACTERIA (1982) (22)
- Production of multiple cytokines by clones of human large granular lymphocytes (2004) (21)
- Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution. (1988) (21)
- In vivo anti‐tumor effects of local adoptive transfer of mouse and human cultured lymphoid cells (1981) (21)
- Physical and functional association of Fc mu receptor on human natural killer cells with the zeta- and Fc epsilon RI gamma-chains and with src family protein tyrosine kinases. (1996) (21)
- Evaluation of the effect of remission plasma on untreated patients with Burkitt's lymphoma. (1970) (21)
- AUGMENTATION OF NATURAL KILLER CELL ACTIVITY OF BEIGE MICE BY INTERFERON AND INTERFERON INDUCERS (1980) (21)
- Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity. (1990) (21)
- Generation of natural killer cells from long-term cultures of mouse bone marrow. (1993) (21)
- Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene. (1990) (21)
- Cytotoxic Antibody in Burkitt's Tumor and Normal Human Serum Reactive with Cultures of Lymphoid Cells (1968) (21)
- Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay. (1978) (21)
- Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays. (1977) (20)
- Prolactin receptor expression by rat NK cells. (1995) (20)
- Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. (1974) (20)
- Carcinoma of the lung: immunotherapy with intradermal BCG and allogeneic tumor cells. (1980) (20)
- Cancer immunotherapy with interleukin-2-activated natural killer cells (2002) (20)
- Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays. (1975) (20)
- Immunotherapy in previously treated acute lymphatic leukemia. (1973) (20)
- Production of both macrophage activating and inhibiting activities by a murine T-lymphocyte hybridoma (1981) (20)
- Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice. (1976) (20)
- Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor. (1986) (20)
- Effect of α-interferons on immune function (1997) (20)
- Delayed hypersensitivity skin reactions to antigens on human tumors (1974) (20)
- Neural modulation of immunity: conditioning phenomena and the adaptability of lymphoid cells. (1992) (19)
- Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. (1975) (19)
- SPECIFICITY OF NK CELLS (1980) (19)
- Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer (2009) (19)
- Immunologic monitoring in carcinoma of the breast. (1977) (19)
- Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration. (1992) (19)
- Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. I. Characteristics of inhibition and evidence for an infectious agent. (1977) (19)
- Immunization by irradiated whole cells or cell extracts against an experimental bladder tumor. (1980) (19)
- Studies on the specificity of human cytotoxic antibody reactive with cultures of lymphoid cells. (1969) (19)
- NATURAL KILLER (NK) CELLS: CHARACTERISTICS AND POSSIBLE ROLE IN RESISTANCE AGAINST TUMOR GROWTH (1985) (19)
- Divergent Phosphotyrosine Signaling via FcγRIIIA on Human NK Cells (1996) (19)
- Detection of humoral antibody response to polyoma tumor-specific cell-surface antigen. (1970) (18)
- Specific afferent interference by antiserum of in vivo immunity (1975) (18)
- CYTOLYSIS OF HUMAN CELLS BY ANTIBODIES IN NORMAL RABBIT SERUM (1969) (18)
- Immune recognition of tumor cells in vivo. I. Role of H‐2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells (1982) (18)
- Natural Killer Cell Activity in the Rat. VI. Characterization of Rat Large Granular Lymphocytes as Effector Cells in Natural Killer and Antibody‐Dependent Cellular Cytotoxic Activities (1987) (18)
- Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity. (1993) (18)
- Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role. (1992) (18)
- Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas. (1978) (18)
- A review of data, problems, and open questions pertaining to in situ tumor immunity. (1980) (18)
- CHARACTERISTICS OF NK CELLS (1980) (17)
- Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2. (1987) (17)
- Effects of Dibutyryl Cyclic Adenosine Phosphate Plus Theophylline on Murine Sarcoma Virus Transformed Non-Producer Cells (1972) (17)
- Purification and characterization of a human lung tumor-associated antigen. (1978) (17)
- Expression of Fcμ receptors on human natural killer cells (1991) (17)
- Immunomodulatory effects of poly(I,C)-LC in cancer patients. (1985) (17)
- Natural killer (NK) cells. (1981) (17)
- Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross virus-induced lymphoma. (1976) (17)
- Interferon and natural killer (NK) cells. (1981) (17)
- Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP. (1982) (17)
- Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. (1989) (16)
- Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium. (1983) (16)
- Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes. (1985) (16)
- ACCELERATION OF METASTATIC GROWTH IN ANTI-ASIALO GM1-TREATED MICE (1982) (16)
- Biological Markers in Breast Cancer (1978) (16)
- Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need. (2006) (16)
- Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies. (1995) (16)
- Location by immunoelectron microscopy of carcinoembryonic antigen on cultured adenocarcinoma cells. (1975) (16)
- Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors (2005) (16)
- Natural killer cells and their possible relevance to transplantation biology. (1982) (16)
- Lack of specificity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T24. (1977) (15)
- Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes. (1988) (15)
- Changes in immune function in patients receiving natural leukocyte interferon. (1983) (15)
- HYPOTHESIS ON THE DEVELOPMENT OF NATURAL KILLER CELLS AND THEIR RELATIONSHIP TO T CELLS (1982) (15)
- Cancer Immunology: Innovative Approaches to Therapy (2012) (15)
- Assay of augmentation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity by interferon. (1981) (15)
- Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers (2004) (15)
- Natural immunity cancer and biological response modification (1986) (15)
- Augmentation of antileukemia lytic activity by OKT3 monoclonal antibody: synergism of OKT3 and interleukin-2. (1987) (14)
- Use of activated natural killer cells for tumor immunotherapy in mouse and human. (2000) (14)
- Therapy of peritoneal murine cancer with biological response modifiers. (1985) (14)
- Delayed cutaneous hypersensitivity reactions to extracts of human tumors. (1973) (14)
- Natural Killer Cell Activity in the Chronic Fatigue-Immune Dysfunction Syndrome (1989) (14)
- Design of clinical trials with biological response modifiers. (1985) (14)
- Natural Killing—Present and Future (Summary of Workshop on Natural Killer Cells) (1983) (14)
- A cytotoxic antiglobulin technique for assay of antibodies to histocompatibility antigens. (1969) (14)
- Natural killer cell precursors in the CD44neg/dim T-cell receptor population of mouse bone marrow. (1996) (14)
- Immune response to Gross virus-induced lymphoma: cryopreservation of functional activity of rat lymphocytes and tumor cells. (1976) (14)
- Can NK cells play a role in therapy of leukemia? (1986) (14)
- NATURAL SUPPRESSOR CELLS FOR MURINE NK ACTIVITY (1982) (14)
- In vitro inhibition of cell-mediated cytotoxicity against syngeneic Friend virus-induced leukemia by immunoregulatory alpha globulin. (1975) (13)
- Studies on the mechanism of low natural killer cell activity in infant and aged mice. (1986) (13)
- Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains. (1978) (13)
- Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus. (1973) (13)
- In vitro Generation and in vivo Effects of Adherent Lymphokine-Activated Killer Cells and IL2 in Patients with Solid Tumors1 (1990) (13)
- Effect of various cytokines and growth factors on the interleukin-2-dependent in vitro differentiation of natural killer cells from bone marrow. (1989) (13)
- Proliferative effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophores on human large granular lymphocytes (LGL). (1988) (13)
- Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon (1981) (13)
- Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice. (1978) (13)
- Assessment of in vivo natural antitumor resistance and lymphocyte (1983) (13)
- INTERFERON AND NK CELLS (1982) (13)
- Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas. (1974) (13)
- Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. (2004) (13)
- Natural killer cells and gene therapy: potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases. (1994) (13)
- Cryopreservation of human mononuclear cells for quality control in clinical immunology. I. Correlations in recovery of K- and NK-cell functions, surface markers, and morphology (1982) (13)
- Immunity to antigens associated with a cell line derived from nasopharyngeal cancer (NPC) in non‐Chinese NPC patients (1976) (13)
- C. PARVUM-INDUCED SUPPRESSOR CELLS FOR MOUSE NK ACTIVITY (1982) (12)
- Natural cytotoxic reactivity of rat lymphocytes against gross virus-induced tumor cell lines as measured by [125I]iododeoxyuridine and tritiated proline microcytotoxicity assays. (1977) (12)
- Extravasation of antitumor effector cells. (1992) (12)
- Influence of the Host on Tumor Development (1989) (12)
- Cutaneous delayed hypersensitivity responses of patients with retinoblastoma to standard recall antigens and crude membrane extracts of retino-blastoma tissue culture cells. (1974) (12)
- Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. I. Basic parameters: baseline controls, target cells, and methods of calculation. (1977) (12)
- The Current Status of Human Monocyte‐Mediated Cytotoxicity Against Tumor Cells (1985) (12)
- Abrogation of the proliferation of human leukemia cells in nude mice by a xenoantiserum. (1979) (12)
- Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies. (1995) (12)
- Mechanisms of Tumor Cell Lysis by Natural Killer Cells (1982) (12)
- CHARACTERISTICS OF AUGMENTATION BY INTERFERON OF CELL-MEDIATED CYTOTOXICITY (1980) (12)
- A trial of autologous plasma perfusion over protein A in patients with breast cancer. (1984) (12)
- Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen. (1978) (12)
- Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF) (1983) (12)
- Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors. (1987) (12)
- Studies of human natural killer cytotoxic factor (NKCF): characterization and analysis of its mode of action. (1985) (12)
- Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth. (1985) (12)
- Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus. (1979) (12)
- Cellular immune reactions to human leukemia. (1972) (12)
- 5'-Nucleotide phosphodiesterase isoenzyme and hepatic cancer in NCI-Mayo Clinic panel sera. (1973) (12)
- SUPPRESSION OF LYMPHOCYTE PROLIFERATIVE RESPONSES BY MURINE LYMPHOMA CELLS (1975) (11)
- Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations. (1979) (11)
- AUGMENTATION OF HUMAN NATURAL KILLER CELLS WITH HUMAN LEUKOCYTE AND HUMAN RECOMBINANT LEUKOCYTE INTERFERON (1982) (11)
- NK Cells and Other Natural Effector Cells (2012) (11)
- Natural killer cells and tumor immunity (1983) (11)
- Spontaneous Cytotoxicity by Monocyte‐Enriched Subpopulations of Human Peripheral Blood Mononuclear Cells against Human or Mouse Anchorage‐Dependent Tumour Cell Lines (1983) (11)
- Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin. (1988) (11)
- Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells. (1985) (11)
- Effect of Antigen Density on Complement-Mediated Lysis, T-Cell-Mediated Killing, and Antigenic Modulation (1974) (11)
- Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice. (1981) (11)
- Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man (2004) (11)
- Interaction of T cells with allogeneic macrophages in mixed leukocyte cultures in rats. (1977) (11)
- Heterogeneity of surface antigens on endogenous type C virus-producing cell sublines derived from a clonal line of BALB/3T3 cells. (1975) (11)
- Systemic and in situ natural killer activity in C57BL/6N and CBA/N mice bearing murine sarcoma virus-induced regressor tumors. (1980) (11)
- Degradation of Enkephalins by Rat Lymphocyte and Purified Rat Natural Killer Cell Surface Aminopeptidases (1993) (11)
- A species of human a interferon that lacks the ability to boost human natural killer activity (1999) (11)
- Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer. (1988) (11)
- Nongranular proteolytic enzymes of rat IL‐2–activated natural killer cells. II. Purification and identification of rat A‐NKP 1 and A‐NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex (1994) (11)
- INTERFERON-INDEPENDENT ACTIVATION OF MURINE NATURAL KILLER CELL ACTIVITY (1980) (11)
- Overview on NK cells and possible mechanisms for their cytotoxic activity. (1982) (10)
- Effect of Carbohydrates on the in vivo Migration of Purified LAK Cells (1989) (10)
- Cytotoxicity inhibition assay: cryopreservation and standardization: brief communication. (1977) (10)
- Skin tests with soluble melanoma antigens in patients with choroidal tumors (1977) (10)
- Inhibition of human natural killer cell activity by polyclonal IgM. (1989) (10)
- Conservation of total T-cell counts during HIV infection: alternative hypotheses and implications. (1998) (10)
- T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells. (1977) (10)
- Variation among mouse strains in responsiveness to migration inhibitory factor. (1979) (10)
- Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL. (1989) (10)
- Natural Killer Cells and Other Effector Cells, and Their Roles in Resistance against Cancer (1983) (10)
- In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide. (1985) (10)
- Increased sensitivity to TNF-mediated cytotoxicity of BL6 melanoma cells after H-2Kb gene transfection. (1993) (10)
- Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor. (1991) (9)
- 51Cr-labeled human hepatocytes as target cells for cytotoxicity mediated by freshly isolated liver-infiltrating lymphocytes. (1993) (9)
- Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF). (1980) (9)
- Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation. (1991) (9)
- Expression of Functional CD 32 Molecules on Human NK Cells Is Determined by an Allelic Polymorphism of the Fc g RIIC Gene (1998) (9)
- Natural killer cells in lungs and other tissues and regulation of their activity by suppressor cells. (1986) (9)
- Changes of liver-resident natural killer cells during liver regeneration in rats (1995) (9)
- Counterpoint: animal tumor models and their relevance to human tumor immunology. (1983) (9)
- Role of interferons in natural killer cell generation from primitive bone marrow precursors. (1988) (9)
- Acute leukemia in identical twins: search for viral and leukemia-associated antigens. (1972) (9)
- Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma. (1975) (9)
- Immunotherapy of advanced melanoma by intratumoral injections of autologous, purified dendritic cells transduced with gene construct of interleukin-12, with dose-dependent expression under the control of an oral activator ligand. (2011) (9)
- Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. (1991) (9)
- Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines. (1983) (9)
- Humoral host defense mechanisms against tumors. (1976) (9)
- Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera. (1971) (9)
- Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas. (1977) (9)
- Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome. (1985) (9)
- Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity. (1994) (9)
- Overview and perspectives: natural resistance mechanisms. (1982) (9)
- Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells. (1977) (9)
- Heterogeneity of Human Natural Killer Cells (1985) (9)
- REGULATION BY INTERFERON AND T CELLS OF IL-2-DEPENDENT GROWTH OF NK PROGENITOR CELLS: A LIMITING DILUTION ANALYSIS (1982) (9)
- Sources of confounding in immunologic data. (1991) (9)
- MODULATION OF NK AND MONOCYTE ACTIVITY IN ADVANCED CANCER PATIENTS RECEIVING INTERFERON (1982) (9)
- Separation of the major histocompatibility antigens from other antigens present on human leukemic and white blood cell membranes. (1973) (8)
- Sequential metabolic events and morphological changes during in vivo large granular lymphocyte activation and proliferation. (1986) (8)
- Killing often spoken of as natural hellip; the cryptic orphan killer cells. (1983) (8)
- The need to develop centers for environmental oncology. (2007) (8)
- Low frequency of NK‐cell progenitors and development of suppressor cells in IL‐2‐dependent cultures of spleen cells from low NK‐reactive SJL/J mice (1986) (8)
- Protection of penetrating corneal allografts from immune rejection. (1972) (8)
- Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells. (1995) (8)
- Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells. (1987) (8)
- Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons. (1983) (8)
- Characteristics of the Ideal Tumor Marker (2003) (8)
- Natural killer cells and their possible roles in host resistance against tumors. (1984) (8)
- Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia. (1992) (8)
- CULTURES OF PURIFIED HUMAN NATURAL KILLER CELLS (1982) (8)
- Immunological study of two stocks of moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice (1978) (8)
- Role of the Natural Immune System in Control of Primary Tumors and Metastasis (1989) (8)
- Summary: potential of interleukin-2 for the therapy of cancer. (1984) (8)
- A novel epitope of N‐CAM defines precursors of human adherent NK cells (2004) (8)
- Surface aminopeptidase activity of rat natural killer cells. I. Biochemical and biological properties. (1994) (8)
- Lymphokine‐activated killer cell activity in patients with primary and metastatic malignant liver tumors (1989) (8)
- Serologic analysis of the antigenic specificities of simian virus 40-transformed cells and their relationship to tumor-associated transplantation antigen. (1974) (8)
- Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice. (1979) (8)
- Immunological Control of Tumor Metastases (1989) (8)
- Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2 (2004) (8)
- THE ROLE OF NEUTRAL SERINE PROTEASES IN THE MECHANISM OF TUMOR CELL LYSIS BY HUMAN NATURAL KILLER CELLS (1982) (8)
- Cytostasis of tumor cell lines by granulocytes from cancer patients and normal human donors (1981) (8)
- A comparison of CEA-S and CEA concentrations in sera and the independence of CEA-S, NCA and blood group antigens. (1976) (7)
- Serum factors in renal carcinoma. (1971) (7)
- Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat. (1991) (7)
- Chemoimmunotherapy of metastatic murine renal cell carcinoma using flavone acetic acid and interleukin 2. (1992) (7)
- Immunological control of breast cancer: discussion. (1976) (7)
- Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat (1991) (7)
- In vitro effects of an acyltripeptide, FK565, on antitumor effector activities and on metabolic activities of human monocytes and granulocytes. (1989) (7)
- Cytophilic immunoglobulins revisited via natural killer cells (1996) (7)
- Alterations in cell-surface carbohydrates of rat large granular lymphocytes associated with interleukin-2 activation. (1990) (7)
- In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. (1979) (7)
- MODULATION OF NK ACTIVITY BY RECOMBINANT LEUKOCYTE INTERFERON IN ADVANCED CANCER PATIENTS (1982) (7)
- Simplified technique for the T-globulin cancer test. (1973) (7)
- Evaluation of a Complement-Dependent Human Cytotoxic Antibody Reactive with Burkitt's Lymphoma Biopsy Cells 1 (1970) (7)
- Tumor-Associated Immunodeficiency and Implications for Tumor Development and Prognosis (2003) (7)
- The FDA Guidance on Therapeutic Cancer Vaccines: The Need for Revision to Include Preventive Cancer Vaccines or for a New Guidance Dedicated to Them (2015) (7)
- Ultraviolet light-induced increase in tumor cell susceptibility to TNF-dependent and TNF-independent natural cell-mediated cytotoxicity. (1991) (7)
- NK cells in cancer immunotherapy: three decades of discovery. (2006) (7)
- Overview on new immunologic markers for diagnosis of cancer (1978) (7)
- ROLE OF NATURAL-CELL-MEDIATED IMMUNITY IN URETHAN-INDUCED LUNG CARCINOGENESIS (1982) (7)
- A PHASE IB TRIAL OF MURINE MONOCLONAL ANTIBODY R24 (ANTI-GD3) IN METASTATIC MELANOMA (1992) (7)
- NATURAL CELL-MEDIATED CYTOTOXICITY AGAINST SPONTANEOUS MOUSE MAMMARY TUMORS (1982) (7)
- Cellular immunity to human tumor-associated antigens. A review. (1973) (7)
- Detection of liver metastases with 5'-nucleotide phosphodiesterase isozyme-V in gastrointestinal cancer patients. (1980) (7)
- Second counterpoint: animal tumor models and their relevance to human tumor immunology. (1983) (7)
- IDENTIFICATION AND CHARACTERIZATION OF THE NATURAL KILLER (NK) CELLS IN RATS (1982) (6)
- Selective augmentation by recombinant interferon-gamma of the intracellular content of S-adenosylmethionine in murine macrophages. (1986) (6)
- Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2. (1978) (6)
- Cell-mediated immunity in human acute leukemia. (1975) (6)
- Psychoneuroimmunology and cancer: fifteenth Sapporo Cancer Seminar. (1996) (6)
- Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma. (1999) (6)
- Delayed Cutaneous Hypersensitivity Reactions to Extracts of Malignant and Normal Human Breast Cells (1973) (6)
- Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents (2004) (6)
- Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response. (1976) (6)
- A Maintainable Superconducting Magnet System for Tokamak Fusion Reactors (1980) (6)
- The human interferons: from the past and into the future. (1984) (6)
- Inhibition of growth of mouse leukemic cell lines in vitro and in vivo by a monoclonal antibody that recognizes an interleukin 3 receptor-associated protein. (1991) (6)
- In vivo and in vitro assays of cellular immunity to human tumor antigens. (1973) (6)
- ANALYSIS OF NATURAL KILLER ACTIVITY OF HUMAN LARGE GRANULAR LYMPHOCYTES AT A SINGLE CELL LEVEL (1982) (6)
- Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes. (1989) (6)
- Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells. (1996) (6)
- Sequential evaluation of cutaneous delayed hypersensitivity responses to recall and to lymphoid cell line antigens in Burkitt's lymphoma (1977) (6)
- Role of CD44 in the development of NK cells from precursors in long-term cultures of mouse bone marrow. (1994) (6)
- Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens. (1973) (6)
- Dissociation of Multiple Polyoma Virus Functions by Ultraviolet Irradiation (1969) (6)
- Therapeutic Efficacy and Systemic Antitumor T Cell Immunity Induced by RheoSwitch-Regulated IL-12 Expression after Intratumoral Injection of Adenovirus Vector or Vector-Transduced Dendritic Cells (2014) (6)
- Cytolytic effects of alloantiserum in patients with lymphoproliferative disorders (1971) (6)
- Hodgkin's disease in siblings: a family study. (1976) (6)
- Conditions for generating and assaying human leukocyte inhibitory factor (LIF) induced by purified protein derivative (PPD). (1978) (6)
- In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells. (1989) (5)
- Immune Responses To Metastases (1996) (5)
- INHIBITION OF NATURAL KILLER CELL CYTOTOXIC REACTIVITY BY TUMOR PROMOTERS AND CHOLERA TOXIN (1982) (5)
- Identification and characterization: cell membrane antigens associated with the blast phase of human adult leukemia. (1975) (5)
- Effects of biological response modifiers on effector cells with cytotoxic activity against tumors. (1986) (5)
- NEGATIVE REGULATION OF HUMAN NK ACTIVITY BY MONOMERIC IgG (1982) (5)
- Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24. (1975) (5)
- Adoptive therapy with purified CD8 cells in HIV infection. (1992) (5)
- REGULATION OF IN VIVO REACTIVITY OF NATURAL KILLER (NK) CELLS (1982) (5)
- Expression of Fc mu receptors on human natural killer cells. (1991) (5)
- Cancer therapy by biological response modifiers. (1987) (5)
- Human Natural Killer Cells in Health and Disease (2012) (5)
- Antileukemia Reactivity of Endogenous and Interleukin-2-Activated Natural Killer Cells (1986) (5)
- Assessment of cellular immune response to cancer of the breast. (1979) (5)
- Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin. (1976) (5)
- Results of an Investigation of Three Clusters of Chronic Fatigue Syndrome (1994) (5)
- Leukemia antigens and immunity in man. (1983) (5)
- Solubilization of G (gross) antigens on the surface of G leukemia cells. (1973) (5)
- Role of natural killer cells and T cells in immune surveillance. (2000) (5)
- Immunobiology of natural killer cells. Volume II (1986) (5)
- Augmentation of NK cell activity by IL-2. (1987) (5)
- INDUCTION OF NK-LIKE ANTI-TUMOR REACTIVITY IN VITRO AND IN VIVO BY IL-2 (1982) (5)
- Activation of natural killer (NK) cells and mechanism of their cytotoxic effects. (1987) (5)
- Compendium of assays for immunodiagnosis of human cancer : proceedings of the Workshop on the Immunodiagnosis of Human Cancer, National Institutes of Health, Bethesda, Maryland, Sept. 11-13, 1978 (1979) (5)
- Immunologically defined prognostic subgroups as predictors of response to BCG immunotherapy. (1982) (5)
- Relationship of mouse natural killer cells to mouse natural cytotoxic cells: Effector cells and possible mechanism of action (1986) (5)
- Cancer therapy by biological response modifiers. (1987) (5)
- The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. (1992) (5)
- DEPRESSION OF NK REACTIVITY IN MICE BY LEUKEMOGENIC DOSES OF IRRADIATION (1982) (5)
- Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo. (1988) (5)
- Effect of various immunoregulatory substances on the growth inhibitory activity (GIA) of human monocytes against lymphoblastoid cell lines. (1982) (4)
- [2] Measurements of natural killer cell numbers and function in humans (1995) (4)
- Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis. (1993) (4)
- ASSESSMENT OF CYTOLYSIS OF TUMOR CELLS BY RELEASE OF [125I]IODODEOXYURIDINE (1981) (4)
- Lymphokine-Activated Killer (LAK) Cells (1998) (4)
- Treatment of canine transmissible venereal tumor by intravenous administration of protein A. (1984) (4)
- Delayed hypersensitivity reactions of cancer patients to antigens on lymphoid cell lines (1978) (4)
- Occult (non-surface expression) of T, B and monocyte markers in human large granular lymphocytes. (1987) (4)
- Participation of three lymphoid cell types in the in vitro activation of cell-mediated immunity to a syngeneic gross virus-induced lymphoma in rats. (1976) (4)
- New immunologic markers for monitoring of cancer. (1989) (4)
- Clinical cancer therapy with IL-2. (1989) (4)
- Partially restorative role of T cells for low interleukin 2 dependent growth of NK cell progenitors from nude mice. (1983) (4)
- Cancer as a chronic inflammatory disease: role of immunotherapy (2004) (4)
- AUGMENTATION OF NATURAL KILLER ACTIVITY BY RETINOIC ACID (1982) (4)
- Natural cell-mediated cytotoxicity against primary mammary tumors. Abstr. (1981) (4)
- Involvement of the 2'-5' A pathway in the augmentation of natural killer activity. (1987) (4)
- Mathematical models of HIV pathogenesis (1997) (4)
- Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells. (1994) (4)
- Characterization of cell lines enhancing IL-2 production by human phytohemagglutinin-stimulated lymphocytes. (1985) (4)
- Summary of the International Cancer Microenvironment from meeting in Pittsburgh, Pennsylvania on October 3-6, 1999. (2000) (4)
- Delayed Hypersensitivity Response toward Autochthonous Tumor Extracts (1974) (4)
- Stress, Natural Killer Cells, and Cancer (2002) (3)
- Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. (1984) (3)
- Induction of Protein Tyrosine Phosphorylation in Human Natural Killer Cells by Triggering Via a 4 pI or a s p I Integrins (2002) (3)
- Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity (1985) (3)
- Nucleases and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice. (1978) (3)
- Polyribonucleotides for cancer therapy: summary and recommendations for further research. (1985) (3)
- $sup 51$Cr-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells (1973) (3)
- Tumor immunology and its application to the diagnosis of cancer. (1974) (3)
- Mouse strain-related differences in the biologic and immunologic responses to a murine sarcoma virus. (1973) (3)
- Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients. (1981) (3)
- PLEIOTROPIC EFFECTS OF INTERFERON (IFN) ON THE AUGMENTATION OF RAT NATURAL KILLER (NK) CELL ACTIVITY (1982) (3)
- Natural killer cell cytolytic granule-associated enzymes. I. Purification, characterization, and analysis of function of an enzyme with sulfatase activity. (1991) (3)
- In vivo effects of cytokines on development of natural killer cells and antitumor activity in lethally irradiated bone marrow transplanted recipients. (1990) (3)
- Natural Killer Cells and Cells Mediating Antibody-Dependent Cytotoxicity against Tumors (1980) (3)
- CHARACTERISTICS OF HUMAN NATURAL KILLER CYTOTOXIC FACTOR (NKCF) LYSIS AND POSSIBLE RELATIONSHIP TO LYSIS BY NK CELLS (1985) (3)
- Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF). (1983) (3)
- In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets (2004) (3)
- Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels (2005) (3)
- Immunological Aspects of Leukemia (1977) (3)
- Depression of 'high affinity' T-cell rosettes indicative of recurrent carcinoma. (1977) (3)
- High incidence of migration inhibition reactivity to lung tumor-associated antigen by normal donors in close contact with lung cancer patients or materials. (1980) (3)
- Natural killer cells and tumor immunity. (1983) (3)
- Natural Killer Cells and Interleukin-2-Activated Killer Cells (1992) (3)
- Natural killer cell function in cancer patients treated with natural leukocyte interferon-alpha. (1986) (2)
- SOURCE AND FUNCTIONAL CHARACTERISTICS OF THE MITOGENIC FACTOR INDUCING CONTINUED PROLIFERATION OF HUMAN T CELLS (1979) (2)
- Potential role of natural antibodies in resistance to tumor growth. (1995) (2)
- Abstract 4272: Elimination of human lung cancer stem cells through targeting of the SCF-c-kit autocrine signaling loop (2010) (2)
- Tumor immunology and immunotherapy (1977) (2)
- ADCC but not NK activity Characterization of a suppressor T-cell chronic lymphocytic leukemia with (2011) (2)
- Mechanism of tumor cell lysis by natural killer cells. (1982) (2)
- Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types. (1989) (2)
- 665 Effect of rhinovirus 39 (RV) infection on immune/inflammatory cell functions (1991) (2)
- Cellular immunity to mouse mammary tumor virus (mtv) in normal and tumor bearing c3h mice. Abstr. (1978) (2)
- Utilization of cryopreserved peripheral blood lymphocytes obtained by leukophoresis as standard controls in lymphocyte stimulation and T-rosette formation. Monitoring of immunf competence in cancer patients☆ (1975) (2)
- Immunologic monitoring and immunotherapy in Ewing's sarcoma (1978) (2)
- Mechanisms of Immunosuppression (2003) (2)
- Expression of murine CD34 by fetal liver NK cell progenitors. (1999) (2)
- Tumor immunology. (1992) (2)
- Biological response modifier therapy : symptom management (1990) (2)
- Cytotoxic Mechanisms of Natural Killer Cells (1997) (2)
- MODELS FOR MECHANISMS OF NATURAL CYTOTOXICITY (1979) (2)
- Partial purification and characterization of a novel human factor that augments the expression of class I MHC antigens on tumour cells (1996) (2)
- STUDIES ON THE NATURE OF THE HAEMOLYTIC ACTIVITY OF TISSUE HOMOGENATES. (1964) (2)
- Non-secretory apoptotic killing of tumor cells by human natural killer cells is mediated by multiple cell membrane bound ligands of the TNF family (1996) (2)
- Effect of immunoregulatory alpha-globulin on in vitro proliferative response of immune rat lymphocytes to syngeneic Gross virus-induced lymphoma. (1974) (2)
- Heterogeneity of human natural killer cells. (1985) (2)
- Carcinogen-induced inhibition of nk activity in mice. Abstr. (1981) (2)
- Mechanisms and Pharmacology of NK Cell Activity (1986) (2)
- In vitro tests of cellular immunity in man. (1978) (2)
- Immunodiagnosis and its applicability for cancer screening. (1978) (2)
- Novel method for benchmarking recruitment of African American cancer patients to clinical therapeutic trials. (2008) (2)
- Evidence for indirect involvement of the H-2Kb gene in the regulation of natural killer sensitivity of BL6 melanoma cells. (1994) (2)
- CELL SURFACE ANTIGENIC CHARACTERISTICS OF RAT LARGE GRANULAR LYMPHOCYTES (LGL) (1982) (2)
- Skin test results with common and melanoma antigens in metastatic melanoma patients being treated with intratumoral injections. (2018) (1)
- Tumor Cells by Human NK Cells Family Ligands in Apoptotic Killing of Constitutive Expression and Role of the TNF (1999) (1)
- Immune responses to virus induced experimental leukemia and to human leukemia. (1974) (1)
- Occult leukocyte and tumor‐associated antigens assessed by flow cytometry: A Review (1988) (1)
- Immunodiagnostics for cancer testing. A look at the future. (1979) (1)
- Re: Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study. (2012) (1)
- Identification and partial purification of a human natural killer cell proliferation-inducing factor (1996) (1)
- Depression of murine macrophage accumulation by factors derived from spontaneous mammary carcinomas. Abstr. (1980) (1)
- Natural killer cell (nk) activity in murine and human tumors. Abstr. (1979) (1)
- New Approaches and Technologies (2003) (1)
- Biological Response Modifiers as Activators of Natural Killer Cells: Potential Role in Treatment of Metastasis (1986) (1)
- Inhibition of NK cell generation by Corynebacterium parvum. (1991) (1)
- Immunological control of virus-associated tumors in man: prospects and problems. Symposium held at the National Institutes of Health, Bcthesda, Maryland, April 7-9, 1975. (1976) (1)
- The use of 5-fluorouracil to enhance natural killer activity in rat bone marrow. (1989) (1)
- Characteristics of LAK Cells and their use in Adoptive Therapy of Cancer in Experimental Animals (1990) (1)
- Cancer-associated serum globulin demonstrated by polyacrylamide gel electrophoresis. (1980) (1)
- ALTERATIONS IN NUMBERS OF LGLs AS IMPORTANT COMPONENT OF IN VIVO REGULATION OF NK ACTIVITY (1985) (1)
- Augmentation of Natural Immunity for the Therapy of Disease (1986) (1)
- A Historical Introduction of Natural Killer (NK) Cells and Current Status of Their Role in Host Defences (2005) (1)
- Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens. (1973) (1)
- CLONED LINES OF MOUSE NATURAL KILLER CELLS (1982) (1)
- Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity (2004) (1)
- Suppression of the generation of cytotoxic lymphoblasts by murine lymphoma cells. Abstr. (1975) (1)
- Therapy of Cancer with Interleukin-2-Activated Natural Killer Cells (1989) (1)
- Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumors (2005) (1)
- Immunochemical characterization of tumor associated surface antigens (tasa) on a moloney murine leukemia virus induced lymphoma, mbl-2. Abstr. (1978) (1)
- Cellular immune reactions in human acute leukemia. (1974) (1)
- Cell-mediated cytotoxic reactions to tumor associated antigens. (1975) (1)
- In Vitro Development of Human NK Cells: Characteristics of Precursors and Effector Cells and Possible Cell Lineage (1980) (1)
- Biological response modifiers for the therapy of cancer. (1985) (1)
- EFFECT OF MACROPHAGE MIGRATION INHIBITORY FACTOR ON PERITONEAL EXUDATE CELLS OF C3H/HeN AND C3H/HeJ MICE (1978) (1)
- Determination of the antigenic content of polyoma tumor specific cell surface antigen. Abstr. (1970) (1)
- Abstract 1546: Combined direct intratumoral adenoviral delivery and production of Rheoswitch®-regulated IL-12 and IFNα enhances antitumor activity in lung and breast cancer models (2012) (1)
- UV LIGHT-INDUCED INCREASE IN IMMUNOGENICITY OF 3LL TUMOR CELLS (1985) (1)
- Cells against syngeneic and allogeneic target cells. (1977) (1)
- Up-regulation of tumor cell sensitivity to natural cell-mediated cytotoxicity by UV light irradiation. (1994) (1)
- Role of Natural Killer (NK) Cells in Resistance to Tumors (1982) (1)
- Prolonged survival of a rabbit skin allograft following corneal transplantation from the same donor. (1973) (1)
- Clinical characteristics and outcomes of South-East Asian patients with Takotsubo ( stress-induced ) cardiomyopathy (2003) (1)
- Evaluation of Immunomodulatory and Therapeutic Properties of Biological Response Modifiers: A Comparison of Preclinical and Clinical Studies (1987) (1)
- ISOLATION OF TUMOR ASSOCIATED ANTIGEN (S) FROM A MOLONEY VIRUS INDUCED LEUKEMIA (MBL-2) (1977) (1)
- Immunology of Oncornaviruses (1982) (1)
- Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity. (1990) (1)
- The effect of lentinan on lymphokine production. Abstr. (1981) (1)
- Book ReviewMediation of Cellular Immunity in Cancer by Immune Modifiers (1982) (1)
- NK cells and tumor immunity: 1984. (1985) (1)
- Cell-mediated immunity to leukemia associated antigens in experimental models and in man. (1976) (1)
- DELAYED CUTANEOUS SENSITIVITY REACTIONS TO AUTOLOGOUS BURKITT LYMPHOMA PROTEIN EXTRACTS (1971) (1)
- Rapid effects of BCG on T cell function in cancer patients (1981) (1)
- Effect of ‘Low-Dose’ Interferon Administration on the Immunological Status of Cancer Patients (1986) (1)
- Immunodiagnostics for Cancer Testing (1979) (1)
- Cytokine Secretion and Noncytotoxic Functions of Human Large Granular Lymphocytes (2019) (1)
- TECHNICAL CONSIDERATIONS FOR THE SEPARATION OF HUMAN PERIPHERAL BLOOD LYMPHOCYTE SUBPOPULATIONS BY ROSETTING WITH SHEEP ERYTHROCYTE (1977) (1)
- Translation of scientific insights to benefit patients with cancer (2004) (1)
- Lack of expression on cultured human T-lymphocytes of a T-cell antigen shared by the molt-4 cell line and normal human thymocytes (1980) (1)
- PHOSPHOLIPID METABOLISM DURING NK CELL ACTIVITY: POSSIBLE ROLE FOR TRANSMETHYLATION AND PHOSPHOLIPASE A2 ACTIVATION IN RECOGNITION AND LYSIS (1982) (1)
- Lymphocyte Cytotoxicity in Human Acute Leukemia (1974) (1)
- Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas. (1980) (0)
- Screening and Early Detection Markers (2003) (0)
- Pathways for Catalysis (1996) (0)
- Cytostatic factors produced by lymphocytes in response to tumor cells (1986) (0)
- Serum and tissue banks for biological markers. (1990) (0)
- Up-regulation of natural killer activity of human immunodeficiency virus-infected patients by in vitro-differentiated macrophages. (1989) (0)
- Cell-mediated cytotoxicity against human tumors: lessons learned and future prospects. (1983) (0)
- Program and abstracts for joint conference of the 17th International Leukocyte Culture Conference and 22nd NATIONAL MEETING OF THE RETICULOENDOTHELIAL SOCIETY (1985) (0)
- 195 Intramuscular Electroporation of an Optimized RheoSwitch®-regulated Interferon Alpha Plasmid Transgene Shows Long Term Persistence in Vivo: Implications for Therapy of Cancer (2012) (0)
- Subject Index Vol. 11, 2004 (2004) (0)
- ADHERENT SUPPRESSOR CELLS IN NORMAL RAT SPLEENS (1977) (0)
- 2270 – IMMUNOENHANCING EFFECT OF ADRIAMYCIN ON RESISTANCE OF LETHALLY IRRADIATED MICE AGAINST TUMOR GRAFTS (1978) (0)
- Regulation of mouse natural killer (NK) activity by interferon-γ (IFN-γ) (1985) (0)
- Letter: Heparin and T-cell rosettes. (1976) (0)
- Activation of suppressor cells after tumor induction and after injec- tion of corynebacterium parvum (cp). Abstr. (1975) (0)
- Human leukocyte migration inhibition factor (LIF) activity in culture supernatants from mixed lymphocyte tumor cell extract interactions (MLTI) (1976) (0)
- Effect of interleukin-2 on the monomeric IgG-induced inhibition of human natural killer cell activity. (1989) (0)
- Fected with mouse mammary tumor virus (mtv). Abstr. (1979) (0)
- Differential recovery of K and NK cell function following cryopreservation of human mononuclear cells (1981) (0)
- IMPROVED GENERATION OF ADHERENT LYMPHO- KINE-ACTIVATED KILLER (A-LAK) CELLS FROM PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (1992) (0)
- Natural cytotoxicity by macrophages. Abstr. (1979) (0)
- Activation and proliferation of normal lymphocytes and hematopoietic cell lines induced by human SCCHN-derived soluble factor (1994) (0)
- Categories and Applications of Tumor Markers (2003) (0)
- blood donors Blood donor Diagnosis Extent of disease Age Sex History of transfusion Carcinoma of bladder Carcinoma of bladder and 6 other primary tumors over past 50 yr Melanoma Carcinoma of bladder Carcinoma of bladder Melanoma (2007) (0)
- Phospholipid methylation and phospholipase A 2 activation in cytotoxicity by human natural killer cells ( 3-deazaadenosine / large granular lymphocytes / antibody-dependent cell-mediated cytotoxicity ) (0)
- Antibody response to tumor specific cell surface antigen and cross reactive antigens in tumor cells. Abstr. (1973) (0)
- Recurrence and Metastasis Markers (2003) (0)
- Phospholipid methylation andphospholipase A2activation in cytotoxicity byhumannatural killer cells (1981) (0)
- Tumor specific antigens in papova-virus-induced tumors. Abstr. (1971) (0)
- Book ReviewMan, Cancer and Immunity (1979) (0)
- An administrative structure for integration of multimodality image implementation and tumor-metric analysis for early assessment of therapeutic response in cancer by Image Response Assessment Teams (IRAT) (2008) (0)
- Secondary cell-mediated cytotoxic response to syngeneic tumors. Abstr. (1975) (0)
- Biological Response Modifiers for the Therapy of Metastases (1986) (0)
- Book ReviewCancer Manual (1987) (0)
- EVIDENCE FOR THE PRESENCE OF TWO NOVEL CYTOKINES IN SUPERNATANTS OF CONCANAVA- LIN A-ACTIVATED HUMAN PERIPHERAL BLOOD LYMPHOCYTES (1992) (0)
- Rapid augmentation of natural killer (nk) cell activity and circulating interferon (if) in mice inoculated with tumor cells. Abstr. (1980) (0)
- Improved utilization of molecular imaging for response assessment in oncologic clinical trials by the University of Pittsburgh Imaging Response Assessment Teams (2007) (0)
- A Preliminary Deals Magnet System Design Study for HFITR (1978) (0)
- Large granular lymphocyte (LGL) subsets with ability to produce B-cell growth factor (1984) (0)
- Current Status and Perspective of Natural Killer Cell Research (1983) (0)
- Issue Information (1984) (0)
- Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells. (1994) (0)
- Regulation of Differentiation of Bone Marrow Precursors into Natural Killer Effector Cells1 (1986) (0)
- Abstract 5384: Tanshinone IIA synergizes with arsenic trioxide to promote human NB4 promyelocytic leukemia cell differentiation and apoptosis (2010) (0)
- Introduction (2001) (0)
- Proteomic Analysis of Post Transplant Lymphoproliferative Disorders (PTLD) Using Nanoscale Protein Microarray Techniques. (2005) (0)
- Squamous Cell Carcinoma of the Head and Neck Human Cytotoxic T-Cell Lines with Restricted Specificity for Updated (2006) (0)
- Lymphokine-activated Killer Cells in Rats : Analysis of Tissue and Strain Distribution , Ontogeny , and Target Specificity 1 (2006) (0)
- Primary and secondary cell-mediated cytotoxic response to friend leukemia. Abstr. (1975) (0)
- Suppression of T-cell mediated lymphokine production but not cytotoxic activity by macrophages. (1980) (0)
- Natural cell-mediated cytotoxic reactivity with mouse leukemia cells. Abstr. (1975) (0)
- NK cells and tumor immunity: 1983 (1984) (0)
- Assessment of biological responses: what to measure and when. (1985) (0)
- Subject Index Vol. 16, 1998 (2000) (0)
- Lymphokines and monokines (1985) (0)
- Contents Vol. 11, 2004 (2004) (0)
- Viruses, Cancer and Immunity (1986) (0)
- Enhancement of mouse natural killer activity by interferon. Abstr. (1978) (0)
- Mechanisms for in vivo Expansion of Natural Killer Cells1 (1986) (0)
- A T LYMPHOCYTE HYBRIDOMA WHICH GENERATES MIF/MAF* (1982) (0)
- Intratumoral Therapy II: In Vitro and In Vivo Immunologic Testing and Therapy Options (2018) (0)
- Leukemia in Identical Twins: New Implications for Viral Oncology. (1971) (0)
- population of mouse bone marrow Natural killer cell precursors in the CD44neg/dim T-cell receptor (2011) (0)
- In vitro detection of cellular and humoral responses to murine sarcoma virus (msv) in mice. Abstr. (1972) (0)
- PHENOTYPIC AND FUNCTIONAL CHARACTERISTICS OF PRECURSORS OF HUMAN LYMPHOKINE ACTIVATED KILLER (A-LAK) CELLS (1992) (0)
- Strategies for enrichment of natural-killer-cell precursors from mouse bone marrow (1994) (0)
- Immune Responses to Metastases, Volumes 1 and 2 (1988) (0)
- Role of IL-2 in Growth and Differentiation of Cytotoxic Cells (2018) (0)
- The Evaluation of Biological Response Modifiers for Cancer Therapy (1989) (0)
- USAGE OF THE T CELL RECEPTOR β CHAIN VARIABLE REGION REPERTOIRE IN TUMOR- INFILTRATING LYMPHOCYTES FROM HUMAN MELANOMA (1992) (0)
- Impaired NK Cell Profile in Leukemia Patients (2019) (0)
- Breast Cancers TRAG-3 in Patients with Melanoma and T Cell Responses against + Spontaneous CD 4 Maillere and (2006) (0)
- Intratumoral Therapy I: Association of Immunotherapy with Permanent Long Term Cure of Metastatic Cancer (2018) (0)
- Natural killer cells and tumor immunity: 1987. (1989) (0)
- Dual effect of interferons on IL-2 induced proliferation of human T cells and large granular lymphocytes (NK) assessed by limiting dilution analysis (1982) (0)
- Generation of NK activity from inactive precursors in mouse NK-long term bone-marrow cultures (NK_LTBMC) depends on PGP-1 (CD44)/hyaluronic acid interaction (1993) (0)
- Proteolytic Enzymes of Adherent Rat Lymphokine-Activated Killer Cells1 (1990) (0)
- Cellular cytotoxicity reactions to human leukemia associated antigens. (1973) (0)
- Leukolysins and Cancer: edited by Janet H. Ransom and John R. Ortaldo, Humana Press, 1988. $69.50 (xviii + 322 pages) ISBN 0 89603 125 X (1989) (0)
- Therapy Selection and Response Markers (2003) (0)
- Inhibition of the Activity of Mouse Natural Killer Cells by U rethan 1 , 2 (2012) (0)
- Andrei Sulica, MD, 1938–2000 (1998) (0)
- IL-2 RECEPTOR (IL-2R) AND CYTOKINE mRNAs PROFILE OF HUMAN ADHERENT LYMPHOKINE ACTIVATED KILLER (A-LAK) CELL PRECURSORS (1992) (0)
- The Influence of Randomized Controlled Cancer Chemoprevention Trials on the Evolution of Regulatory Assessments (2011) (0)
- SIMILARITIES AND DIFFERENCES BETWEEN RAT AND MOUSE LONG-TERM BONE MARROW CULTURES (LTBMC) FOR NATURAL KILLER (NK) CELLS (1992) (0)
- Natural killer cells and tumor immunity: 1985. (1986) (0)
- Skin test results with common and melanoma antigens compared to clinical outcomes of melanoma patients treated with intralesional (IL) dinitrochorobenzene (DNCB) or IL bacillus Calmette-Guerin (BCG). (2017) (0)
- TOWARD THE DEVELOPMENT OF ENVIRONMENTAL ONCOLOGY (2004) (0)
- To the editor (2004) (0)
- Reply to the Letter to the editors by A. Maghazachi (1992) (0)
- Enhanced MHC I antigen expression on tumour target cells is inversely correlated to lysis by allogenic but not by xenogenic NK cells (1995) (0)
- National Cancer Institute Serum Immunodiagnostic Bank at Mayo Clinic — 10 Years Experience (1984) (0)
- Different murine thymus-derived lymphocyte subpopulations identified by their differential susceptibility to cryopreservation☆ (1975) (0)
- Current Concepts and Future Prospects for Immunotherapeutic Approaches in Cancer Treatment (1994) (0)
- Editorial (2000) (0)
- Organ Site-Specific Markers (2003) (0)
- Anti‐tumor effect by dendritic cells stimulated with IL‐2 in OT‐1 model (2008) (0)
- Phase I-II vaccine trial with MHC class II and MHC class I epitopes from Melan-A/MART-1 for patients with metastatic melanoma. (2004) (0)
- Tum or Immunology and Its Application to the Diagnosis o f Cancer (2015) (0)
- ROSETTING WORKSHOP SUMMARY (1979) (0)
- Abstract 4396: Combination of intratumoral regulated IL-12 gene delivery and systemic chemotherapy with Palifosfamide (IPM-Tris) enhances anti-tumor effects in breast cancer (4T1) model (2012) (0)
- Figure 15-3, [A, Immune effector cells release...]. (2003) (0)
- Activation of protein tyrosine kinases in human NK cells by triggering via FC-mu receptor (1994) (0)
- In Vivo Tissue Distribution of Interleukin-2 Activated Cells (2018) (0)
- Letter: Tumor-associated antigen in female and male breast cancer. (1975) (0)
- Competence of Cellular Immunity System Three aspects of the competence of the cellular immunity system in acute leukemia (2005) (0)
- Documentation of Immune Suppression in Cancer Patients (2003) (0)
- Relationship of the tumor specific antigens and the histocompatibility antigens in polyoma tumor. Abstr. (1971) (0)
- Dr. Ronald B. Herberman's reply (1983) (0)
- Mechanisms of the Antimetastatic Effects of Anticoagulant Drugs: Dependence on Natural Killer (NK) Cell Activity (2019) (0)
- Traditional Tumor Markers (2003) (0)
- Interferon and Inducers: Regulatory Effects on Cellular Functions (1983) (0)
- Spontaneous in vivo cytolytic activity of mice against tumor cells. Abstr. (1979) (0)
- Stress, Coping, and Infectious Illness: Persistently Low Natural Killer Cell Activity as a Host Risk Factor. (1988) (0)
- Acknowledgment of Reviewers (2003) (0)
- Mechanisms of metastasis: Potential therapeutic implications (2004) (0)
- A Novel Method for Benchmarking Clinical Trial Recruitment of African American Cancer Patients (2007) (0)
- CULTURE OF NK CELLS: SPECIFICITY, PHENOTYPES, FUNCTIONS AND COMPARISON WITH ACTIVATED T CELLS (1985) (0)
- DIFFERENT T CELL DEPLETION METHODS RESULT IN DIFFERENT NUMBERS OF CELLS WITH NATURAL KILLER SURFACE MARKERS AND CYTOLYTIC ACTIVITY AFTER LONG-TERM CULTURE OF MOUSE BONE MARROW CELLS (1992) (0)
- Summary of Workshop on “Lymphokines Activating Cells for Killer Functions” (1987) (0)
- Natural Killer Cell Granule Associated Chondroitin Sulfate Proteoglycan: Structure and Role in Cytolytic Function (1990) (0)
- Defective response to migration inhibition factor by peritoneal macrophages from c3h/hej mice. Abstr. (1978) (0)
- Lymphokine-activated Killer Cells in Rats : Analysis of Progenitor and Effector Cell Phenotype and Relationship to Natural Killer Cells 1 (2006) (0)
- Isolation of Effector Cells from the Liver (2003) (0)
- The requirement for h-2 compatible macrophages for the generation of migration inhibition factor by immune t cells in response to soluble tumor antigens. Abstr. (1977) (0)
- Quantitation of immunocompetence in patients with lung cancer. (1977) (0)
- The T-Cell Receptor β Chain Variable Region Repertoire in Fresh and Cultured Lymphocytes Isolated from Human Malignant Melanomas (1994) (0)
- Cross-talk between c gamma RIIA and c gamma RIIc on human natural killer cells (1999) (0)
- In vitro correlates of cell-mediated immunity to experimental and human leukemia. (1975) (0)
- The effect of non-specific immune stimulation on corneal allograft survival in rabbits. (1974) (0)
- Foreword (1983) (0)
- Regulation of Cytolytic Activity of Fresh and IL2-Activated Human Natural Killer Cells by Anti-CD 16 Monoclonal Antibodies (1990) (0)
- Abstract 1891: Tanshinone IIA is a novel agent for melanoma prevention and therapy (2010) (0)
- Fetal antigens and tumor specific cell surface antigens of papova virus-induced tumors. Abstr. (1972) (0)
This paper list is powered by the following services:
Other Resources About Ronald B. Herberman
What Schools Are Affiliated With Ronald B. Herberman?
Ronald B. Herberman is affiliated with the following schools:
